Off-Label Promotion

Off-label promotion refers to the marketing of prescription drugs for uses that the U.S. Food and Drug Administration (FDA) has not officially approved. While doctors can prescribe medications for off-label purposes, pharmaceutical companies are prohibited from promoting these uses without proper FDA approval. This practice raises concerns about patient safety, as the effectiveness and side effects of medications for unapproved uses may not be well-studied. Off-label promotion can lead to legal issues for companies and has sparked debates about medical ethics and industry regulation.